We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,777 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
TIDMGSK
RNS Number : 7172X
GlaxoSmithKline PLC
23 February 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ======================================================================== a) Name Dr M M Slaoui === ======================== ============================================== b) Position/status Chairman, Global Vaccines === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of GlaxoSmithKline plc American Depositary the financial Shares ('ADSs') instrument ISIN: US37733W1053 === ======================== ============================================== b) Nature of the An increase of 53 ADSs following the notional transaction allocation of ADSs on 22 February 2017, at a price of $41.03 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $41.03 53 --------- ---------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2017-02-22 === ======================== ============================================== f) Place of the n/a transaction === ======================== ============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================================== a) Name Dr K Slaoui === ======================== ============================================== b) Position/status PCA of Dr M M Slaoui (Chairman, Global Vaccines) === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of GlaxoSmithKline plc American Depositary the financial Shares ('ADSs') instrument ISIN: US37733W1053 === ======================== ============================================== b) Nature of the An increase of 13 ADSs following the notional transaction allocation of ADSs on 22 February 2017, at a price of $41.03 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $41.03 13 --------- ---------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2017-02-22 === ======================== ============================================== f) Place of the n/a transaction === ======================== ==============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEXLFLDLFBBBZ
(END) Dow Jones Newswires
February 23, 2017 10:07 ET (15:07 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions